CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Ordinary shares	Additional paid-in capital	Accumulated other comprehensive income (loss)	Retained earnings (accumulated deficit)
Beginning balance (in shares) at Dec. 31, 2024		108,516,819
Beginning balance at Dec. 31, 2024	$ 360,179		$ 1,519,809	$ (5,500)	$ (1,154,130)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation to employees	29,552		29,552
Exercise of options and vested RSUs (in shares)		2,965,781
Exercise of options and vested RSUs	5,247		5,247
Other comprehensive income (loss), net of tax benefit of $0	1,299			1,299
Net income (loss)	(34,319)				(34,319)
Ending balance (in shares) at Mar. 31, 2025		111,482,600
Ending balance at Mar. 31, 2025	361,958		1,554,608	(4,201)	(1,188,449)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss), net of tax benefit	0
Beginning balance (in shares) at Dec. 31, 2024		108,516,819
Beginning balance at Dec. 31, 2024	360,179		1,519,809	(5,500)	(1,154,130)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(136,227)
Ending balance (in shares) at Dec. 31, 2025		112,492,667
Ending balance at Dec. 31, 2025	340,466		1,634,264	(3,441)	(1,290,357)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation to employees	63,009		63,009
Exercise of options and vested RSUs (in shares)		3,328,273
Exercise of options and vested RSUs	390		390
Tax payment related to net share settlement on equity awards	(556)		(556)
Other comprehensive income (loss), net of tax benefit of $0	(1,454)			(1,454)
Net income (loss)	(71,138)				(71,138)
Ending balance (in shares) at Mar. 31, 2026		115,820,940
Ending balance at Mar. 31, 2026	330,717		$ 1,697,107	$ (4,895)	$ (1,361,495)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss), net of tax benefit	$ 0